VistaPharm, LLC announced the FDA approval of its methadone hydrochloride oral solution, effectively adding a new competitor to the market for a controlled substance that has historically faced significant supply shortages. This entry allows increased manufacturing capacity and competition, potentially stabilizing pricing and improving patient access to this essential pain management medication.